Loading chart…
LIVE
Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS.
Suraksha Diagnostic Limited (SURAKSHA) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The SURAKSHA share price is ₹350.50 (+5.26% today), with a market capitalisation of ₹18B and a price-to-earnings (P/E) ratio of 52.5. MarketRipple tracks the SURAKSHA investment thesis, the ripple-chain impact of market events on Suraksha Diagnostic Limited, and the Healthcare sector outlook.
Open
₹346.00
High
₹359.50
Low
₹341.55
Prev. Close
₹333.00
52W High
₹360.00
52W Low
₹224.10
Day range
₹341.55–₹359.50
52-week range
₹224.10–₹360.00
Volume
134K
P/E
52.5
ROE
13.1%
D/E
0.53
Margin
11.0%
Suraksha Diagnostic Limited (NSE: SURAKSHA) is currently trading at ₹350.50 (+5.26%).
Suraksha Diagnostic Limited's market capitalization is ₹18B.
Suraksha Diagnostic Limited's price-to-earnings (P/E) ratio is 52.5.
Suraksha Diagnostic Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Suraksha Diagnostic Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.